Company Registration No. 09012535 (England and Wales)
ROUNDWAY THERAPY LIMITED
ANNUAL REPORT AND
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024
PAGES FOR FILING WITH REGISTRAR
ROUNDWAY THERAPY LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
ROUNDWAY THERAPY LIMITED
BALANCE SHEET
AS AT
30 APRIL 2024
30 April 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
306,204
320,205
Current assets
Debtors
5
164,597
164,443
Cash at bank and in hand
462,986
417,490
627,583
581,933
Creditors: amounts falling due within one year
6
(79,050)
(95,817)
Net current assets
548,533
486,116
Net assets
854,737
806,321
Capital and reserves
Called up share capital
100
100
Profit and loss reserves
854,637
806,221
Total equity
854,737
806,321

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 20 September 2024
Dr C R Aldred
Director
Company Registration No. 09012535
ROUNDWAY THERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2024
- 2 -
1
Accounting policies
Company information

Roundway Therapy Limited is a private company limited by shares incorporated in England and Wales. The registered office is 2 Roundway, Bramhall, Stockport, Cheshire, United Kingdom, SK7 1DG.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention.The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, being language and speech therapy.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Land and buildings Leasehold
Plant and machinery
10% and 33% straight line
Fixtures, fittings & equipment
15% reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

ROUNDWAY THERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2024
1
Accounting policies
(Continued)
- 3 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

 

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
ROUNDWAY THERAPY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 APRIL 2024
- 4 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 May 2023 and 30 April 2024
316,667
48,399
365,066
Depreciation and impairment
At 1 May 2023
20,775
24,086
44,861
Depreciation charged in the year
9,596
4,405
14,001
At 30 April 2024
30,371
28,491
58,862
Carrying amount
At 30 April 2024
286,296
19,908
306,204
At 30 April 2023
295,892
24,313
320,205
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
18,197
22,212
Other debtors
146,400
142,231
164,597
164,443
6
Creditors: amounts falling due within one year
2024
2023
£
£
Taxation and social security
20,995
42,351
Other creditors
58,055
53,466
79,050
95,817
2024-04-302023-05-01false20 September 2024CCH SoftwareCCH Accounts Production 2024.210No description of principal activityDr C R Aldredfalsefalse090125352023-05-012024-04-30090125352024-04-30090125352023-04-3009012535core:LandBuildings2024-04-3009012535core:OtherPropertyPlantEquipment2024-04-3009012535core:LandBuildings2023-04-3009012535core:OtherPropertyPlantEquipment2023-04-3009012535core:CurrentFinancialInstrumentscore:WithinOneYear2024-04-3009012535core:CurrentFinancialInstrumentscore:WithinOneYear2023-04-3009012535core:CurrentFinancialInstruments2024-04-3009012535core:CurrentFinancialInstruments2023-04-3009012535core:ShareCapital2024-04-3009012535core:ShareCapital2023-04-3009012535core:RetainedEarningsAccumulatedLosses2024-04-3009012535core:RetainedEarningsAccumulatedLosses2023-04-3009012535bus:Director12023-05-012024-04-3009012535core:PlantMachinery2023-05-012024-04-3009012535core:FurnitureFittings2023-05-012024-04-30090125352022-05-012023-04-3009012535core:LandBuildings2023-04-3009012535core:OtherPropertyPlantEquipment2023-04-30090125352023-04-3009012535core:LandBuildings2023-05-012024-04-3009012535core:OtherPropertyPlantEquipment2023-05-012024-04-3009012535core:WithinOneYear2024-04-3009012535core:WithinOneYear2023-04-3009012535bus:PrivateLimitedCompanyLtd2023-05-012024-04-3009012535bus:SmallCompaniesRegimeForAccounts2023-05-012024-04-3009012535bus:FRS1022023-05-012024-04-3009012535bus:AuditExemptWithAccountantsReport2023-05-012024-04-3009012535bus:FullAccounts2023-05-012024-04-30xbrli:purexbrli:sharesiso4217:GBP